1. P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry. (16th January 2018) Authors: Chaparro, M; Garre, A; Alfaro, I; Iborra, M; Mesonero, P; Vera Mendoza, I; Rodríguez, A; Miquel-Cusachs, J; Riestra, S; Navarro, P; De Castro Parga, L; González-Muñoza, C; Rivero, M; Mañosa, M; Fernández Salazar, L; Jiménez, N; Guardiola, J; Cabriada, J; Gutiérrez Casbas, A; Sicilia, B Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P666 Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry. (16th January 2018) Authors: Chaparro, M; Garre, A; Alfaro, I; Iborra, M; Mesonero, P; Vera Mendoza, I; Rodríguez, A; Miquel-Cusachs, J; Riestra, S; Navarro, P; De Castro Parga, L; González-Muñoza, C; Rivero Tirado, M; Mañosa, M; Fernández Salazar, L; García-Sepulcre, M; Guardiola, J; Cabriada, J; Gutiérrez Casbas, A; Sicili... Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗